Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 updates the page framework without altering study data or critical details like eligibility or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed. This appears to be a minor page version update with no changes to study content or scheduling.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays the actual 'Results First Posted' and 'Last Update Posted' dates, replacing the previous estimated dates. This clarifies when results were posted and when the record was last updated.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision indicator updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA new Locations section is introduced with California listed as a location. The page revision has been updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure and the prior California Locations heading were removed.SummaryDifference0.2%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.